Contact Precautions for ESBL E. coli from Urine

Rationale for Exempting ESBL E. coli from Contact Precautions

The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines specifically exempt E. coli from contact precaution requirements, even when it produces extended-spectrum beta-lactamases (ESBLs), due to its different epidemiology and transmission patterns compared to other ESBL-producing organisms 1, 2, 3.
The exemption for E. coli is explicitly stated in the guidelines, indicating that ESBL E. coli is treated differently from other ESBL-producing Enterobacteriaceae 1, 2.

Hand hygiene remains essential and should be performed with alcohol-based hand rub before and after all patient contacts, as recommended by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) 1, 3.
Soap and water hand washing is required when hands are visibly soiled with body fluids or excretions, such as urine, according to the ESCMID guidelines 1, 3.
Regular environmental cleaning procedures should be implemented, including detergents or disinfectants according to local practice, as recommended by the ESCMID 3.

Contact precautions are strongly recommended for non-E. coli ESBL-producing Enterobacteriaceae, including wearing gloves and gowns before entering the patient's room, as recommended by the ESCMID 1, 4.
Isolation in a single room is conditionally recommended to reduce transmission risk for non-E. coli ESBL-producing Enterobacteriaceae, according to the ESCMID guidelines 1, 2.

ESBL-producing E. coli infections are associated with higher healthcare costs and poorer clinical outcomes compared to non-ESBL-producing strains, as reported in studies 6, 7.
ESBL-producing E. coli often exhibits co-resistance to other antibiotics, including trimethoprim-sulfamethoxazole, tetracycline, gentamicin, and ciprofloxacin, according to research findings 6.

Implement antimicrobial stewardship programs to limit the use of specific antimicrobial agents based on patients' comorbidities, as recommended by the ESCMID 3.
In settings with high incidence of ESBL-producing Enterobacteriaceae, extended use of cephalosporins should be discouraged, according to the World Health Organization 8.

Do not confuse recommendations for ESBL E. coli with those for other ESBL-producing Enterobacteriaceae, which do require contact precautions, as emphasized by the ESCMID 1, 2.
Do not neglect standard precautions, which remain essential for all patient care regardless of known infection status, as recommended by the ESCMID 1, 3.